News
The section includes updates and press releases from hepCoalition and partner organizations. Includes highlights of upcoming events, actions, and important meetings.
Calendar
Curated list of key international conferences and meetings related to hepatitis C, substance user health, and harm reduction.
Partner News
The section includes updates from partner organizations on related advocacy efforts.
As Evidence Mounts That ‘War on Drugs’ Has Failed, Harm Reduction Advocates Call for New Policies
Leading proponents of drug-policy reform who have gathered at the International Harm Reduction Conference say the evidence is in that it is time for the world to adopt a new approach. More
Unitaid Makes US$31 Million Investment in Harm Reduction Efforts to Prevent Hepatitis C Among People who Inject Drugs and Others at High Risk
Unitaid’s funding will support the integration of hepatitis C testing and treatment within harm reduction programs and trial the use of two products to prevent infection. More
Press Releases
Press releases from hepCoalition and partner organizations.
LAT CAB Calls on AbbVie, Licensed Generic Manufacturers of G/P, and the Medicines Patent Pool to Fulfill their Commitment to Make Generic HCV Treatment Widely Available
Four years after MPP and AbbVie came to agreement on a voluntary license authorizing MPP to sublicense G/P to generic manufacturers, generic G/P is not available anywhere. More
Advocates Urge Cepheid to Reinstate Plans to Commercialize GeneXpert Omni
Advocates call out Cepheid for canceling commercialization of the portable point-of-care GeneXpert Omni testing instrument and urge the company to reinstate plans to launch Omni. More
